C12N 2710/24221
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2710/24221 (Viruses as such) appears on 3 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 7
- Assignees
- 6
- Inventors
- 11
- Latest grant
- 22 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 2 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 2 |
By publication year.
Recent patents
- Oncolytic virus expressing a car t cell target and uses thereof18 Dec 2025US 2025/0381237 A1City of Hope
- Mutant orf viruses and uses thereof19 Jun 2025US 2025/0197815 A9Suzhou Prajna Biotech Co., Ltd.
- Modified parapoxvirus having increased immunogenicity8 Feb 2024US 2024/0043870 A1Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
- Mutant orf viruses and uses thereof26 Oct 2023US 2023/0340424 A1Suzhou Prajna Biotech Co., Ltd.
- Oncolytic virus expressing a car t cell target and uses thereof9 Jul 2020US 2020/0215132 A1City of Hope
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.